At last, there is some good news for the thousands of children who suffer from the killer Japanese encephalitis (JE) across the country, particularly in eastern Uttar Pradesh, every year. India on Friday launched its indigenously manufactured vaccine that would prevent this disease among children. The vaccine being used at present is imported from China and the government often had problems with its procurement, but the domestically prepared vaccine would be readily available, both in the government-run immunisation programme and in the open market. The price is being negotiated. he new vaccine, JENVAC, available in single and double dose, has been manufactured by Genome Valley-based Bharat Biotech. JENVAC has shown superior safety and immunogenicity; the phase III trials showed 98.7 per cent protection 28 days after the first dose and 99.8 per cent sero-protection 28 days after the second dose. The results have shown that the vaccine can be administered as a single dose during epidemics for mass vaccination campaigns and also as a two-dose schedule during routine immunisation.
Posted on: Mon, 07 Oct 2013 08:24:11 +0000
Trending Topics
Recently Viewed Topics
© 2015